Zhejiang Hisoar Pharmaceutical Co., Ltd.
SHZ: 002099.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Guorui Xu
- Employees
- 2,611
- Headquarters
- Taizhou, China
- IPO year
- 2006
- Market cap
- CN¥9.5B
- Website
- https://www.hisoar.com
Loading 002099…
Loading profile data…Frequently asked questions about 002099
What does Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) do?
Zhejiang Hisoar Pharmaceutical Co., Ltd., a pharmaceutical company, produces and sells fine chemicals and special raw drugs in China and internationally. It offers antibiotic, anti-virus, cardiovascular, sugar-reducing, and other materials; and medicine intermediates, and other customized and processed products, such as clindamycin, 4-AA Iso-car...
Where does 002099.SZ trade?
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) trades on the Shenzhen Stock Exchange.
What sector is 002099.SZ in?
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Zhejiang Hisoar Pharmaceutical Co., Ltd.?
Guorui Xu is the chief executive officer of Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ).
Where is Zhejiang Hisoar Pharmaceutical Co., Ltd. headquartered?
Zhejiang Hisoar Pharmaceutical Co., Ltd. is headquartered in China.
Does 002099.SZ pay a dividend?
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 002099.SZ go public?
Zhejiang Hisoar Pharmaceutical Co., Ltd. (002099.SZ) completed its initial public offering in 2006.